IDEA Fund News & Updates

MTC awards $2.55 million in the October 2024 investment cycle

During the October 2024 Board of Directors meeting, $2.55 million was approved for equity-based investments in Missouri-based startups through the IDEA Fund, supporting high-growth potential technologies.

IDEA Fund Impact

Investing in Missouri's innovation economy

2.55M

October 2024 Awards

18M+

Total Awarded Since 2023

64+

Startups Supported

October 2024 Investment Details

During the October 2024 Board of Directors meeting, $2.55 million was approved for equity-based investments in the following companies: TechLaunch (Interplay, Queritel dba Figozo), Seed Capital (AirSeal CardioVascular, Cofactor Genomics, Ferris Genomics, P

Explore Awarded Companies

Meet the October 2024 Portfolio

  • TechLaunch — Interplay turns your dog’s crate into a home with their patent-pending product, the PlayTach. Queritel dba Figozo combines rewards, patient financing, and ecommerce into a dedicated mobile app for medical practices.
  • Seed Capital — AirSeal CardioVascular is developing the first-in-class blood test for diagnosing peripheral arterial disease (PAD). Cofactor Genomics bridges the precision medicine gap by decoding RNA. Ferris Genomics provides innovative DNA analysis. PVPallet builds a.
  • Proof of Concept — Antiger Therapeutics engineers recombinant human leukocyte antigens (HLA) for targeted immunotherapies. AskSAMIE helps older adults stay safe at home through AI-organized resources. Bold Xchange makes sending local eGift cards swift and seamless.

Related Posts

You might also like

Stay Connected with MTC

Can't find what you're looking for? Have a suggestion? Let us know. Want to stay up to date on the Missouri Technology Corporation? Join our mailing list.